European Case Law Identifier: | ECLI:EP:BA:2006:T060404.20060316 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 16 March 2006 | ||||||||
Case number: | T 0604/04 | ||||||||
Application number: | 92910478.4 | ||||||||
IPC class: | C12N 15/12 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Human PF4A receptors and their use | ||||||||
Applicant name: | GENENTECH, INC. | ||||||||
Opponent name: | SmithKline Beecham plc | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request - claims 21 and 22 - sufficiency of disclosure - no Auxiliary request I - inventive step - yes Auxiliary request I - industrial applicability - yes |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t040604eu1.html
Date retrieved: 17 May 2021